AJ

Aleyamma Joseph

Director Director DIN 08389765
DIN 08389765 First appointment Mar 2019 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Mar 2019
Shareholding value Locked Premium profile

About Aleyamma Joseph

Data last updated:

Aleyamma Joseph has 7 years in corporate governance. Formerly with 1 company, such as Medivast Pharmatech Private Limited. Engaged in Technology. Contributes to corporate operations.

DIN 08389765
Primary Designation Director
First Appointment 31 Mar 2019
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Medivast Pharmatech Private Limited U51909TG2018PTC128562
Additional Director31 Mar 20192018Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Medivast Pharmatech Private Limited
Premium access

Shareholding and investment profile for Aleyamma Joseph

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Aleyamma Joseph

Aleyamma Joseph has 7 years in corporate governance. Formerly with 1 company, such as Medivast Pharmatech Private Limited. Engaged in Technology. Contributes to corporate operations.

Aleyamma Joseph is associated with 0 companies as a director.

Aleyamma Joseph has expertise in Technology.

Aleyamma Joseph has 7 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available